Willis-Knighton Cancer Center operates at a scale that rivals academic programs, without the administrative constraints of an academic environment. The center spans multiple floors, runs several subspecialized tumor boards each week, and has access to technology and subspecialty support that most community programs cannot offer. Physicians in this group have built their practices over decades by saying yes to patients and building referral relationships across a large regional catchment area.
The Cancer Center draws from a broad catchment area covering northwest Louisiana, southern Arkansas, east Texas, and parts of Mississippi. The region is predominantly rural outside Shreveport-Bossier, meaning WK serves as the only high-level oncology resource for a large population. The group is currently adding approximately 100 new patients per week across the system.
Senior partners see 40 to 50 outpatient visits per day, plus 10 to 35 inpatient consults during weeks on call. One partner's hematology panel is booked more than three months out for new patients. An APP has been added to help manage inpatient volume, and the outpatient infusion center operates through the end of the day with at least one physician remaining available until all infusions are complete.
Top disease volumes include breast, upper GI, colon, and hematologic malignancies. GI oncology volume is growing, reflecting national trends toward younger patients presenting with colorectal cancer. GU oncology is an identified gap the group is looking to fill through subspecialization.
The incoming physician's first contract covers inpatient oncology hospitalist coverage at Piermont Hospital. Inpatient consults include a mix of malignant and benign hematology cases, including anemia, thrombocytopenia, and newly diagnosed cancers requiring workup and treatment planning. This role is compensated on a separate RVU-based inpatient contract with no overhead.
The Cancer Center's ancillary and subspecialty infrastructure is extensive. Key resources available to the incoming oncologist:
| Board | Schedule |
|---|---|
| General Oncology | Monday, 7:30 AM |
| Breast | Wednesday |
| Hepatobiliary | Wednesday |
| Head and Neck | Weekly |
| Thoracic | Weekly |
| GU | In development |
The group does not perform bone marrow transplant or CAR-T therapy. Patients requiring these treatments are referred to LSU Health (which recently added a strong BMT director), MD Anderson, Baylor, or UT Southwestern. The group has established referral relationships with all of these programs.
Call rotates Q7 among the seven group partners. One physician covers Monday to Monday, then has six weeks off from call. During call weeks, the on-call physician typically runs a half-day clinic and then rounds on inpatient cases, which range from 10 to 35 patients. The group added an APP extender to assist with inpatient volume.
Residents from WK's GME programs rotate through the inpatient oncology service. Clinic-based teaching is optional and at each physician's discretion. The group is building its pharmaceutical clinical trial program and views research participation as a meaningful supplement to clinical income.